The DEA begins reviewing its proposal to move cannabis to Schedule III, even as reform advocates criticize their exclusion ...

There was no discussion of the lasting harms of marijuana criminalization itself—the arrests, convictions, incarceration and collateral consequences that continue to affect individuals, families and ...

Last December, President Trump signed an executive order calling for the rescheduling of marijuana. The DEA is now ...

The DEA's cannabis rescheduling hearing runs through a July 15 deadline, putting cannabis stocks and the MSOS ETF in focus.

The MSOS cannabis ETF hit a 2026 high ahead of the DEA's July 15 rescheduling deadline, as Trulieve, Curaleaf and Canopy Growth reshape the sector.

This may be an encouraging sign for those advocating for the rescheduling of cannabis in a way that will survive the inevitable legal challenge(s) that would follow rescheduling.” By Brett Schuman and ...

(Bloomberg) -- Though marijuana is now legal in 24 US states for recreational purposes and in 40 states for medical reasons, it’s still illegal at the federal level. But on April 23, the US Justice ...

For years, the Drug Enforcement Administration has classified marijuana as a Schedule I substance, alongside many harmful drugs, including heroin, ecstasy, and LSD. Recently, U.S. President Donald ...

On December 18, 2025, President Donald J. Trump issued an Executive Order titled Increasing Medical Marijuana and Cannabidiol Research. The Order directs the Attorney General (“AG”) to take steps to ...

Tens of millions of Americans turn to cannabis products every week to try to ease their pain, calm their anxiety, get more sleep, help them cope with the side effects of chemotherapy, or just relax ...